Moderator
Sandra Nestler-Parr, MPhil, MSc, PhD, Biocryst Pharmaceuticals, Weybridge, United Kingdom
This opening plenary challenges a fundamental assumption in HEOR: that current approaches to measurement fully capture what matters in healthcare decision-making. Drawing on behavioral science, wellbeing research, and health economics, the session will examine how widely used measures—while valuable—may overlook broader dimensions of value, including wellbeing, happiness, daily functioning, societal contributions, and lived experience.
The discussion will explore how what we choose to measure shapes priorities, incentives, and decisions across healthcare systems—and the risks of optimizing for what is easily quantified rather than what truly matters. A moderated interview and audience discussion will consider how broader measures of value could be incorporated into policy and HTA frameworks, the trade-offs involved, and whether today’s systems are equipped to support a more holistic, outcomes-driven approach to healthcare decision-making.
Topic
Economic Evaluation, Health Technology Assessment, Patient-Centered Research